Adrenocortical carcinoma · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Mitotane monotherapy N/A - secondary systemic drug | — | R 0 | 28d | — | — | — | — | — |
Mitotane and Streptozocin N/A - secondary systemic drug | — | R 0 | 21d | — | — | — | — | — |
Observation Partial | — | — | — | ~10.3 mo | ~37.1 mo | — | — | 65 |
3 of 3 regimens shown